Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
93.21
+1.04 (1.13%)
Jul 14, 2026, 4:00 PM EDT - Market closed
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $1.37 billion as of July 14, 2026. Its market cap has increased by 554.66% in one year.
Market Cap
1.37B
Enterprise Value
1.39B
1-Year Change
554.66%
Ranking
Category
Stock Price
$93.21
Market Cap Chart
Since May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $1.37B, an increase of 589.83%. That is a compound annual growth rate of 148.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 1.37B | 19.02% |
| Dec 31, 2025 | 1.15B | 415.39% |
| Dec 31, 2024 | 222.93M | 12.46% |
| May 29, 2024 | 198.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Savara | 1.47B |
| Aktis Oncology | 1.42B |
| Corvus Pharmaceuticals | 1.29B |
| Immatics | 1.28B |
| Ardelyx | 1.27B |
| Jade Biosciences | 1.25B |
| MannKind | 1.23B |
| First Tracks Biotherapeutics | 1.20B |